Pearl River Capital, LLC Iovance Biotherapeutics, Inc. Transaction History

Pearl River Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $150,392 - $232,026	-12,148 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $201,049 - $335,649	12,148 New	12,148 $232,000
Q2 2021 Aug 13, 2021	SELL	$16.33 - $33.07 $298,006 - $603,494	-18,249 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $302,898 - $555,613	10,565 Added 137.49%	18,249 $578,000
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $67,352 - $120,724	-2,402 Reduced 23.82%	7,684 $357,000
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $315,351 - $412,513	-11,364 Reduced 52.98%	10,086 $332,000
Q2 2020 Aug 10, 2020	BUY	$27.21 - $41.0 $583,654 - $879,450	21,450 New	21,450 $589,000
Q1 2019 May 02, 2019	SELL	$8.41 - $11.26 $5,887 - $7,882	-700 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$7.51 - $11.93 $5,257 - $8,351	700 New	700 $6,000

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.48B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.